Assessing Parathyroid Glands Vascularisation by ICG Fluoroscopy
Parathyroid Function Low Adverse Event
About this trial
This is an interventional prevention trial for Parathyroid Function Low Adverse Event focused on measuring Parathyroid gland angiography, Parathyroid gland indocyanine green angiography, Parathyroid gland indocyanine green fluoroscopy
Eligibility Criteria
Inclusion Criteria:
- Adult patients undergoing total thyroidectomy or a totalisation thyroid procedure.
- Patients capable of understanding and able to understand the study.
- Values visually 2 and ICG 2
Exclusion Criteria:
- Parathyroid disease or prior parathyroidectomy
- Lack of informed consent
- Altered mental status of the patient.
- ICG values <2.
Sites / Locations
- University Hospitals Geneva
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
New treatment
Standart treatment
In patients with at least one well perfused parathyroid gland on ICG parathyroid angiography, no postoperative parathyroid dosage and supplementation will be done. Calcium and parathormone dosage will be done 10 days after surgery.
In those patients in whom at least on of the four parathyroid glands is well perused, postoperative parathyroid function test and parathyroid supplementation will be done. Calcium and parathormone dosage will be done at 24 hours and 10 days after surgery. Prophylactic supplementation of calcium and Vitamin D will be given.